Mr Ho Nhan (born 1966) – General Director of the Nanogene Pharmaceutical Biotechnology Joint Stock Company is well known for his participation in the research of the COVID-19 vaccine being tested in Vietnam – Nannocovax. In addition, he is also known as a giant with great wealth, the son-in-law of the Son Kim family – a multi-industry business empire ranging from fashion, retail to real estate.
Mr. Ho Nhan grew up in the US and after earning his doctorate in Biotechnology from the University of Arizona, he and his friends opened research and analysis companies for chemical and pharmaceutical companies.
Mr Ho Nhan is a giant with great wealth, the son-in-law of the Son Kim family – a multi-industry business empire ranging from fashion, retail to real estate.
In 2008, he decided to return to Vietnam to settle down. He opened a small laboratory in the district of Tan Phu (HCMC). Then he moved the facility to the High-Tech Park in Ho Chi Minh City. He has shared his experience in biotechnology research for 20 years. So he went step by step from a small investment, creating a clinical trial product into a big investment. And when there is a profit, he heavily “raises” research.
Currently, Mr. Ho Nhan leads the vaccine company Nanocovax. The company was founded in 1997 with an initial rental capital of up to 200 billion VND as he is the legal representative. Thus, the shares were divided as follows: Mr. Ho Nhan contributed VND 140 billion, holding 70% of the shares; Miss Hong Van – Mr Ho Ngan’s wife contributed 50 billion dong, held 25% stake and Mr Ho Vu Thanh contributed 10 billion dong, owned 5% stake.
At present, the rental capital of the company, led by Mr. Ho Nhan as general director, has increased to 715 billion VND. In which, foreign shareholders hold more than 22.7% of the company’s shares, the rest are owned by family members Mr. Ho Nhan and Ms. Hong Van.
Currently, Mr. Ho Nhan leads the vaccine company Nanocovax.
The company’s main production lines include the production of pharmaceuticals, pharmaceutical chemicals and pharmaceutical materials. Currently, the company has 4 production bases and a research and development center covering an area of up to 73,000 m2.2 – The second largest Hi-tech Park in Ho Chi Minh City.
In early 2020, the company Nanogen was the only unit involved in the production of the first COVID-19 vaccine produced by Vietnam and tested on humans. After more than 4 months of research, the company has successfully researched an S-protein-based vaccine candidate (wild type and 4 mutant forms). The vaccine absorbs aluminum particles and uses special adjuvants to stimulate humoral and cellular immune responses.
The vaccine will begin human trials from December 2020. To date, Nanocovax is Vietnam’s first COVID-19 vaccine to implement its third clinical trial (TNLS), with 13,000 participants, aged 18, including the elderly and people with medical conditions. According to the research team, the Nanocovax vaccine meets safety and immunogenicity requirements.
Mr Ho Nhan informed, the project so far has cost the company more than 200 billion VND, with 100 employees working in the laboratory.However, recently, he said that after researching the Nanocovax vaccine, he left it to others.
On March 18, the Government Office sent a document to convey the opinion of Deputy Prime Minister Vu Duc Dam on the results of the consideration of granting registration for the circulation of the Nanocovax vaccine.
In addition to biotechnology research, Mr. Ho Nhan also invests in many other fields such as the securities or services industry. In particular, he owns more than 300,000 shares, is a major shareholder of One World Service Joint Stock Company with an ownership rate of up to 15.8% (as of November 2016); is a member of the Board of Directors of a leading securities company in Vietnam (from April 2013 to September 2017).
Mr Ho Nhan’s marriage to the eldest daughter of the Son Kim family made many people curious. Because they rarely appear together in front of the press and media. It is only known that Ms. Hong Van followed in his mother’s footsteps from the very beginning, having founded Hong Van Co., Ltd., which specializes in the production of apparel for export.
Ms. Hong Van – wife of Mr. Ho Nhan and mother, Mrs. Nguyen Thi Son – founder of Son Kim Group
Currently, Ms. Hong Van holds a 22.5% stake in Nanogen and is also the director of this company. In addition, Ms. Van and Ms. Putra – biological mother, younger brother and several other family members also contributed capital to establish the Southeast Asia Education Development Investment Joint Stock Company – owner of Duy Tan Middle School in Ho Chi Minh City.
Hong Van was once commented by his biological mother to have intelligent and sensitive qualities in management. It was Putra’s mother who taught her daughter the learning-by-doing method, without holding back but still accumulating practical experience.
It is known that Mr Ho Nhan and Miss Hong Van have 2 daughters who are also very talented.
at Blogtuan.info – Source: Eva.vn – Read the original article here
